C
9.80
0.31 (3.27%)
| Penutupan Terdahulu | 9.49 |
| Buka | 9.77 |
| Jumlah Dagangan | 323,462 |
| Purata Dagangan (3B) | 4,764,126 |
| Modal Pasaran | 85,286,656 |
| Harga / Buku (P/B) | 2.10 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 May 2025 - 16 May 2025 |
| Margin Keuntungan | -167.29% |
| Margin Operasi (TTM) | -334.91% |
| EPS Cair (TTM) | -2.02 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -13.20% |
| Nisbah Semasa (MRQ) | 11.11 |
| Aliran Tunai Operasi (OCF TTM) | -16.53 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -10.69 M |
| Pulangan Atas Aset (ROA TTM) | -42.95% |
| Pulangan Atas Ekuiti (ROE TTM) | -69.95% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | CervoMed Inc. | Menurun | Menurun |
AISkor Stockmoo
0.3
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -1.5 |
| Purata | 0.30 |
|
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 33.38% |
| % Dimiliki oleh Institusi | 17.22% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 21.00 (Canaccord Genuity, 114.29%) | Beli |
| Median | 15.00 (53.06%) | |
| Rendah | 10.00 (D. Boral Capital, 2.04%) | Beli |
| Purata | 16.20 (65.31%) | |
| Jumlah | 5 Beli | |
| Harga Purata @ Panggilan | 8.45 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| D. Boral Capital | 13 May 2025 | 10.00 (2.04%) | Beli | 8.70 |
| 26 Mar 2025 | 10.00 (2.04%) | Beli | 7.71 | |
| Chardan Capital | 12 May 2025 | 15.00 (53.06%) | Beli | 9.10 |
| 18 Mar 2025 | 14.00 (42.86%) | Beli | 9.34 | |
| Canaccord Genuity | 18 Mar 2025 | 21.00 (114.29%) | Beli | 9.34 |
| Roth MKM | 18 Mar 2025 | 20.00 (104.08%) | Beli | 9.34 |
| 11 Mar 2025 | 15.00 (53.06%) | Beli | 2.36 | |
| Jones Trading | 13 Mar 2025 | 15.00 (53.06%) | Beli | 5.79 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |